Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
COV2-2196 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022 2 4
COV2-2130 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022 2 4
COV2-2381 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 3 0
COV2-2050 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 3 0
CoV2-09 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-06 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
CoV2-14 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0
Cov2-16 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021 1 0